Lemaitre Vascular Inc [NASDAQ: LMAT] jumped around 1.61 points on Thursday, while shares priced at $86.28 at the close of the session, up 1.90%.
Compared to the average trading volume of 223.33K shares, LMAT reached a trading volume of 184020 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Lemaitre Vascular Inc [LMAT]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for LMAT shares is $105.62 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on LMAT stock is a recommendation set at 2.09. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for Lemaitre Vascular Inc shares, keeping their opinion on the stock as Perform, with their previous recommendation back on February 28, 2025. The new note on the price target was released on February 28, 2025, representing the official price target for Lemaitre Vascular Inc stock. Previously, the target price had yet another raise to $95, while Wells Fargo analysts kept a Equal Weight rating on LMAT stock.
The Average True Range (ATR) for Lemaitre Vascular Inc is set at 4.05, with the Price to Sales ratio for LMAT stock in the period of the last 12 months amounting to 8.85. The Price to Book ratio for the last quarter was 5.77, with the Price to Cash per share for the same quarter was set at 13.29. Price to Free Cash Flow for LMAT in the course of the last twelve months was 52.38 with Quick ratio for the last quarter at 11.02.
How has LMAT stock performed recently?
Lemaitre Vascular Inc [LMAT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.05. With this latest performance, LMAT shares gained by 1.72% in over the last four-week period, additionally sinking by -5.44% over the last 6 months – not to mention a rise of 34.56% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for LMAT stock in for the last two-week period is set at 53.60, with the RSI for the last a single of trading hit 59.62, and the three-weeks RSI is set at 50.25 for Lemaitre Vascular Inc [LMAT]. The present Moving Average for the last 50 days of trading for this stock 88.78, while it was recorded at 84.44 for the last single week of trading, and 91.40 for the last 200 days.
Lemaitre Vascular Inc [LMAT]: Deeper insight into the fundamentals
Lemaitre Vascular Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 11.02 and a Current Ratio set at 12.85.
Earnings analysis for Lemaitre Vascular Inc [LMAT]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for LMAT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Lemaitre Vascular Inc go to 12.49%.
Insider trade positions for Lemaitre Vascular Inc [LMAT]
There are presently around $95.52%, or 104.80%% of LMAT stock, in the hands of institutional investors. The top three institutional holders of LMAT stocks are: BLACKROCK INC. with ownership of 3.48 million shares, which is approximately 15.4815%. CONESTOGA CAPITAL ADVISORS, LLC, holding 1.94 million shares of the stock with an approximate value of $$159.75 million in LMAT stocks shares; and CONESTOGA CAPITAL ADVISORS, LLC, currently with $$128.07 million in LMAT stock with ownership which is approximately 6.9594%.
